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ABSTRACT
MATERNAL DIABETES AND PERINATAL OUTCOMES
A MASTER’S THESIS
by
Rachael E.Gainor
Diabetes is a serious problem in the nation and in the state of West Virginia (WV). Having
diabetes during pregnancy has been associated with several negative perinatal outcomes. This
study was done to test the hypothesis that women with diabetes would have more negative
perinatal outcomes than those who do not. A secondary hypothesis was women with pregestational diabetes would have more negative perinatal outcomes than women with gestational
diabetes.
This was a population-based study with a causal-comparative (ex post facto) research
design using secondary data analysis. The independent variables were the presence or absence
of diabetes as well as type of diabetes in the mothers. The dependent variable was perinatal
outcomes.
Data were analyzed for the years 2001 and 2002 on all babies born to mothers enrolled
in the West Virginia Medicaid program. Data for those two years were analyzed using three
different databases including WV Vital Statistics, the WV Birth Score Project and WV Medicaid
Claims. There were a total of 14, 583 births included in the population. The population was split
into two groups according to the presence of diabetes in the mother. This was determined using
ICD-9 codes for diabetes in the Medicaid Claims data. The diabetic group consisted of 853
women while the non-diabetic group consisted of 13,750 women. The diabetic group was then
divided into those women with pre-gestational diabetes and those women with gestational
diabetes. The pre-gestational group consisted of 396 women while the gestational group
consisted of 457 women.
The results of this study showed significant associations between the presence of
diabetes in mothers and several negative perinatal outcomes including macrosomia, pre-term
delivery and less than optimal one-minute Apgar scores. Also, pre-gestational diabetes was
shown to be significantly associated with more negative perinatal outcomes than was gestational
diabetes. These perinatal outcomes included macrosomia, pre-term birth, less than optimal
Apgar scores, occurrence of complications of labor and/or delivery and occurrence of congenital
anomalies.
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INTRODUCTION
Overview
The purpose of this study was to research and analyze the effects of maternal diabetes
on perinatal outcomes. It was hypothesized that in West Virginia women, pregnancies
complicated by maternal diabetes are linked to more negative perinatal outcomes than are
pregnancies to mothers without diabetes. A secondary hypothesis analyzed was that Type 1 and
Type 2 diabetes (pregestational) are associated with more severe negative perinatal outcomes
than is gestational diabetes (GDM). Three statewide databases were analyzed to test these
hypotheses. These databases included the West Virginia Vital Registration, the West Virginia
Birth Score Project, and West Virginia Medicaid claims data. Data were analyzed for the
combined years of 2001 and 2002.
Justification of the Study
It has been established that diabetes is a serious public health problem in West Virginia.
It has also been shown that diabetes complicates many pregnancies in the state (Thoenen,
Gravely, Wright & Spiroff, 2001). Research has shown that diabetes during pregnancy is
associated with several negative perinatal complications. Mothers with diabetes and their infants
will continue to be at risk for diabetes related complications to pregnancy until better solutions for
prevention are found.
Birth outcomes of diabetic mothers compared to non-diabetic mothers were analyzed
using the WV Vital Registration data and the WV Birth Score Project data. Negative birth
outcomes and their association with a specific type of diabetes were analyzed using Medicaid
claims data. Analyzing data from all three of these databases and comparing the results will be
beneficial to future research in this field. Data analyzed in this study will be used in future
projects in West Virginia designed to improve the outcomes of pregnancies complicated by
pregestational or gestational diabetes.
Statement of the Problem
There is a lack of state data for West Virginia that compares specific types of birth
outcomes of babies born to mothers with diabetes compared to mothers without diabetes. There
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is also a deficiency of research that compares perinatal outcomes of women with pregestational
diabetes and GDM with those of non-diabetic women from the same population base.
Purpose of the Study
The purpose of this study was to determine the existence of negative birth outcomes
associated with diabetes and to begin to measure the extent of those negative outcomes. In
addition, this research compared pregestational diabetes with gestational diabetes to measure
any difference between their effects on pregnancy outcomes. This research was done to better
help women in West Virginia with diabetes have healthier pregnancies.
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REVIEW OF LITERATURE
Introduction
Diabetes has increasingly become a very serious problem in the United States over the
last few years and West Virginia is no exception to this. According to the 1999 Behavioral Risk
Factor Surveillance System, the prevalence of diabetes in West Virginia has remained high over
the last 10 years. In fact, West Virginia ranks fourth highest in the nation in adults who have been
told by their doctors that they have diabetes (Thoenen, Gravely, Wright, Spiroff, 2001). It is no
surprise then that a large number of pregnancies occurring in the state are in some way
complicated by diabetes. West Virginia, as indicated by Thoenen et al. (2001), has the nation’s
highest percentage of diabetes as a medical risk factor during pregnancy.
A further complicating factor is that diabetes during pregnancy, whether it is pregestational (onset before pregnancy occurs) or gestational (onset during pregnancy), can lead to
adverse outcomes for both mother and infant.
What is Diabetes Mellitus?
The definition of diabetes mellitus, according to The Expert Committee on the Diagnosis
and Classification of Diabetes Mellitus (2002), is several metabolic diseases characterized by
some degree of hyperglycemia. Hyperglycemia, or high levels of blood glucose, is caused by
deficiencies in insulin secretion, insulin action, or both. These insulin deficiencies can be caused
by a range of pathogenic processes from autoimmune destruction of the beta cells of the
pancreas, which make and secrete insulin, to abnormalities that can result in insulin resistance.
Diabetes can lead to several chronic conditions such as cardiovascular complications,
neuropathy (disease of the nerves), nephropathy (disease of the kidneys), and retinopathy
(disorder of the retina) which is the leading cause of blindness in the United States. There are
several non-modifiable risk factors for these problems such as duration of diabetes, age, genetics
and race, as well as modifiable risk factors such as glycemic control and hypertension (Franz,
2001).
Diabetes mellitus (DM) is categorized into three main types—type 1 DM, type 2 DM, and
Gestational (GDM). In the Report of the Expert Committee on the Diagnosis and Classification of
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Diabetes Mellitus (2002), up-to-date definitions for each type of diabetes were given. Type 1 DM
is classified as a total deficiency in secretion of insulin. Type 2 DM, which is much more
prevalent, is classified as a combination of resistance to insulin action and inadequate insulin
secretion. Type 1 and type 2 DM may be referred to as pregestational diabetes, because
diagnosis occurred before pregnancy. GDM is defined as any degree of glucose intolerance with
onset or first diagnosis during pregnancy.
Diabetes-Related Complications to Pregnancy
There are several complications that can occur for both mother and baby when a mother
has diabetes during pregnancy. Congenital anomalies are common among infants born to
diabetic mothers (American Diabetes Association, 2002; Brydon, Smith, Proffitt, Gee, Holder &
Dunne, 2000; Casson et al., 1997; Dunne, Brydon, Smith & Gee, 2003; Farrell, Neale & Cundy,
2002; Harvard, 2002; Langer & Conway, 2000; Loffredo, Wilson & Ferencz, 2001; Moore, Singer,
Bradlee, Rothman & Milunsky, 2000; Penny, Mair & Pearson, 2003; Platt et al., 2002; Sendag,
Terek, Itil, Oztekin & Bilgin, 2001; Thoenen et al., 2001; Uvena-Celbrezze & Catalano, 2000;
Väärasmäki, Gissler, Ritvanen & Hartikainen, 2002). Fetal loss is another common outcome of
diabetic pregnancies (Brydon et al., 2000; Casson et al., 1997; Dunne et al., 2003; Hawthorne,
Irgens, & Lie, 2000; Langer & Conway, 2000; Lauenborg et al., 2003; Penny et al., 2003; Platt et
al., 2002; Uvena-Celebrezze & Catalano, 2000; Wylie et al., 2002). Types of fetal loss include
spontaneous abortion, stillbirth, and perinatal mortality. Excessive fetal growth, referred to as fetal
macrosomia or large for gestational age infants, is a common characteristic in infants born to
diabetic mothers (American Diabetes Association, 2003; Brown & Hare, 1995; Brydon et al.,
2000; Casson et al., 1997; Davey, 2003; Dunne et al., 2003; Hsu-Hage & Yang, 1999; Jensen,
Sörensen, Feilerg-Jörgensen, Westergaard & Beck-Nielsen, 2000; Jovanovic, 2001; Lee-Parritz
& Heffner, 1995; Penny et al., 2003; Platt et al., 2002; Svare, Hansen & Mölsted-Pedersen, 2001;
Thoenen et al., 2001; Wylie et al., 2002)). Complications of labor and delivery, such as cesarean
section and preterm delivery, occur more often in pregnancies complicated by diabetes compared
to those that are not (Blatman & Barss, 1995; Dunne et al., 2003; Harvard, 2002; Jensen et al.,
2000; Svare et al., 2001; Thoenen et al., 2001; Wylie et al., 2002).
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Diabetes during pregnancy can also mean adverse outcomes for the mother.
Pregnancy-induced hypertension occurs more frequently among diabetic mothers than nondiabetic mothers (American Diabetes Association, 2003; Cundy et al., 2002; Dunne et al., 2003;
Hsu-Hage & Yang, 1999; Jensen et al., 2000; Sendag et al., 2001; Sibai et al., 2000; Wylie et al.,
2002). Increased severity of preexisting diabetes-related complications is also a maternal
complication of a diabetic pregnancy (Brown & Hare, 1995; Rosen & Miodovnik, 2000; Thoenen
et al., 2001).
The level of risk for and severity of these complications will depend on several factors,
some of which include the previous health of the mother and her glycemic control during
pregnancy. This review of literature will focus on the complications of maternal diabetes that
occur most frequently.
Congenital Anomalies
Congenital anomaly is defined by Reeder, Martin and Koniak-Griffen (1997) as “an
abnormality present at birth,” which could mean “the absence of a normal structure, the presence
of an abnormal structure, the disruption of the shape, size, or location of a normal structure, or
abnormal measurements”. Thoenen et al. (2001) states that diabetes ranked second in maternal
risk factors for congenital anomalies (sometimes referred to as congenital malformations or
defects) in babies born in West Virginia from 1990-1999. These authors as well as Langer and
Conway (2000) confirmed that congenital anomalies are a leading cause of perinatal deaths in
infants of diabetic mothers. Harvard (2002) stated that, historically, diabetic mothers have had a
3-fold increased risk in having an infant with severe malformations including those of the brain,
spinal cord, and lungs. The American Diabetes Association (2002) affirmed that major congenital
malformations are the primary cause of death and serious morbidity in the infants of women who
have either type 1 DM or type 2 DM.
Much research has been done on the association between an increased risk of having an
infant with one or more congenital anomalies and having type 1 DM during pregnancy. Platt et al.
(2002), in a 5-year population cohort study of 547 pregnancies of women with type 1 DM, found
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that the women with type 1 DM had 6.4 times the risk of having offspring with a congenital
anomaly than did the general population.
In a five year population cohort study including 462 pregnancies, 355 of those being
“insulin dependent diabetics” (term used for type 1 DM in 1997), Casson et al. (1997) found that
infants born to women with “insulin dependent diabetes” had a 10-fold greater risk of congenital
malformation than infants in the general population. They found that the greatest number of
congenital anomalies in their study were cardiovascular system defects. The authors also
reported that the infants with congenital anomalies born to diabetic mothers weighed less than
the other infants in the study.
Penny et al. (2003) found similar results in a national population-based study on the
outcomes of pregnancies in type 1 DM mothers in Scotland. They looked at 273 pregnancies of
women with Type 1 DM. Within the sample they found 13 confirmed congenital anomalies, which
is a rate of 60 per 1000 births. This rate was higher than the non-diabetic comparison group.
Severe congenital anomalies were detected antenatally in 6 of the 13 pregnancies complicated
by congenital anomalies; these included three central nervous system anomalies, two
chromosomal anomalies, and one cardiac anomaly. These cases ended in termination of the
pregnancy.
In more severe cases of infants born with congenital anomalies, death can be the result
even without early termination of the pregnancy. In these cases stillbirth and perinatal mortality
are the outcome. In a “first-year of life” surveillance of infants born with congenital anomalies to
mothers with Type 1 DM, Väärasmäki et al. (2002) found several adverse outcomes linked to
having Type 1 DM during pregnancy. This was a population-based cohort study using data from
four national health registers in Finland from 1991-1995. The study included 954 singleton
pregnancies complicated by type 1 DM. Their results concluded that of 60 births involving
congenital anomalies, the rate of death from birth to one year of life was higher among the infants
of diabetic mothers compared to infants of non-diabetic mothers. This was especially true in
instances of stillborns. Total post-neonatal deaths were four-fold in the diabetic sample. The
most common congenital anomalies in this study were cardiac anomalies, while distress due to
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respiratory anomalies was the leading cause for death to the live-born infants. The authors
summarized that despite efforts to improve the care of the type 1 DM mothers, the infants born to
these women had an increased risk of congenital anomalies, particularly among males.
Several studies have looked at the association between congenital anomalies and having
type 2 DM during pregnancy. Dunne et al. (2003) did an analysis of 12 years of outcome data of
pregnancy in women with type 2 DM. They analyzed data on 182 pregnancies occurring from
1990-2002 using a regional computerized database system. Their results showed that women
with type 2 DM were 11 times more likely to have an infant with a congenital malformation than
the general population.
In a comparison of 57 mothers with type 2 DM to 196 mothers with type 1 DM, Brydon et
al. (2000) found that the rate of congenital malformations in live births of type 2 diabetics was
double that of type 1 diabetics. The authors of this study point out, however, that the mothers
with type 2 DM were older, weighed more and were of greater parity than the mothers with type 1
DM.
A study by Loffredo et al. (2001) reported that pregestational maternal diabetes (includes
both type 1 DM and type 2 DM) is associated with an increased risk of cardiovascular
malformations of early embryonic origin.
GDM is not commonly associated with an increased risk for congenital anomalies. In an
analysis of 128 consecutive pregnancies complicated by GDM and 138 consecutive pregnancies
of non-diabetic controls, Sendag et al. (2001) found no difference in the rate of congenital
anomalies between the two groups. In a review of literature on infants of women with GDM,
Uvena-Celebrezze and Catalano (2000) reported that within current literature on the topic, infants
of women with GDM carry the same risk for congenital anomalies as the non-diabetic population.
They did, however, site one study that found an increased risk for anomalies commonly found in
infants of type 1 DM mothers in infants of mothers with type 2 DM and GDM. They attributed
these cases to possible undiagnosed cases of type 2 DM.
Farrell et al. (2002) found similar results when they researched congenital anomalies in
the offspring of women with type 1 DM, type 2 DM, and GDM in pregnancies occurring between
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1985 and 2000. They found that those women who were likely to have undiagnosed type 2 DM
(according to early postpartum oral glucose tolerance tests) had the same rate of congenital
anomalies in their offspring as those women with established type 1 or type 2 DM. In the
remainder of the women with GDM, the rates of congenital anomalies did not differ from the
nondiabetic population.
A study by Moore et al. (2000) looked at the risk of congenital defects associated with
maternal diabetes and maternal obesity. They found that women who were diabetic,
pregestational or gestational, and were obese had a higher rate of infants with congenital defects
than those women who were only obese or only diabetic.
To summarize, according to current research, infants born to mothers with either type 1
DM or type 2 DM are at a much higher risk for developing a congenital anomaly than infants born
to the nondiabetic population (American Diabetes Association, 2002; Brydon et al., 2000; Casson
et al., 1997; Dunne et al., 2003; Harvard, 2002; Langer & Conway, 2000; Loffredo et al., 2001;
Moore et al., 2000; Penny et al., 2003; Platt et al., 2002; Thoenen et al., 2001; Väärasmäki et al.,
2002). It has also been stated that infants with congenital anomalies born to women with type 1
DM are at a higher risk for death from birth to one year of life than infants with congenital
anomalies born to non-diabetic mothers (Väärasmäki et al., 2002). Infants born to women with
GDM may be at an increased risk for congenital anomalies (Sendag et al., 2001), especially if
their mothers have undiagnosed type 2 DM (Uvena-Celbrezze & Catalano, 2000; Farrell et al.,
2002) or are obese (Moore et al., 2002).
Spontaneous Abortion, Stillbirth, and Perinatal Mortality
Although some authors list several terms for fetal loss, spontaneous abortion, stillbirth,
and perinatal mortality are the three that are most commonly referred to within current literature.
Reeder et al. (1997) defined “spontaneous abortion,” sometimes referred to as miscarriage, as an
abortion (“termination of the fetus before the age of viability”) caused by natural causes. These
authors defined “perinatal mortality” as a rate of both fetal and neonatal (from birth through the 1st
28 days of life) deaths. Thomas (1977) defined “stillbirth” as the birth of a dead fetus.
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Maternal type 1 DM is a well-established cause of spontaneous abortion, stillbirths and
perinatal mortality. Casson et al. (1997) reported a fourfold increase in perinatal death and a
fivefold increase in stillbirths in the type 1 DM group compared to the general population. Platt et
al. (2002) found similar results, reporting that the infants of mothers with type 1 DM had an
increased rate of 5.1 times for perinatal mortality compared to those infants of the general
population. Penny et al. (2003) also found mortality rates higher than those of the background
population.
There are many possible explanations for the increase in fetal death among women with
type 1 DM. In an audit on stillbirths in women with pregestational type 1 DM between the years
1990-2000, Lauenborg et al. (2003) found that type 1 women experiencing stillbirth were
characterized by higher rates of diabetic nephropathy, previous stillbirths, suboptimal glycemic
control, smoking and a lower socioeconomic status. Langer and Conway (2000) did a study of
level of glycemia, which is the level of sugar or glucose in the blood (Thomas, 1997), and
perinatal outcomes. They comment that analysis of cases of fetal death of mothers with
pregestational diabetes reveals abnormal glycemic levels of the mother. These authors also
stated-, however, that even with optimal glycemic control, any type of diabetes causes an
increased risk of perinatal mortality because of the associated risk factors such as hypertension.
Wylie et al. (2002) researched perinatal outcomes after making an attempt to control for
several risk factors and reported positive results. After a 10-year study of 300 consecutive
pregnancies of 247 women with type 1 DM, these researchers found a perinatal mortality rate
lower than that of the control population from the same hospital. During this study participants
were asked to check their blood glucose levels at least four times a day to ensure optimal glucose
control. Insulin needs were carefully monitored and were adjusted as needed by a team of
nurses and physicians educated in diabetes care. The women were seen in the clinic 2 or more
times a week with all medical and obstetrical decisions being made on an individual basis, not
with formal protocols. The authors attributed the lower rate of perinatal mortality to this improved
level of care. They also stated that the control group’s perinatal mortality rate was higher than
that of the Type 1 group because it reflected the high-risk pregnancies common to that hospital.
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Each one of these studies advocated better prenatal care focusing on improvement of
glycemic control for women with type 1 DM in order to improve pregnancy outcomes (Casson et
al., 1997; Platt et al., 2002; Penny et al., 2003; Lauenborg et al., 2003; Wylie et al., 2002)
Type 2 DM has also been linked to fetal death. In fact, Brydon et al. (2000) found that
the live birth rate was lower for type 2 diabetic mothers than for type 1 diabetic mothers in their
sample population. The authors also reported that type 2 mothers in their study had double the
rate of early pregnancy loss (<24 wks. gestation) than that of type 1 mothers. They attributed
these results to lack of attendance for pre-pregnancy care, late booking for antenatal care, and
poor glycemic control by mothers with type 2 DM compared with type 1 mothers. These authors
stressed the importance of educating women of childbearing age with type 2 DM, as well as their
healthcare providers, that type 2 DM is just as serious as type 1 DM and should be treated as
such with optimal glycemic control and prenatal care.
Dunne et al. (2003) reported similar adverse outcomes of pregnancies complicated by
maternal type 2 DM. They found that infants of women with type 2 DM had a 2-fold increased
risk of being stillborn; a 2.5-fold increased risk of perinatal mortality; a 3.5-fold increased risk of
death within the first month after birth; and a 6-fold increased risk of death up to one year
compared with the infants from both regional and national figures.
Several studies have looked at the effects on fetal loss by pregestational diabetes,
without deciphering between type 1 and type 2 DM. Hawthorne et al. (2000) did one such study.
They looked at all pregnancies of women with pregestational diabetes in Norway and England
between July 1994 and June 1997. Perinatal mortality in England among infants born to mothers
without diabetes during this time period was 10/1000, while perinatal mortality among infants born
to mothers with pregestational diabetes was 42.8/1000. These authors found surprising results
when they looked at the same statistics in Norway. Perinatal mortality in Norway among infants
born to mothers without diabetes was 6.7/1000, while perinatal mortality among those infants
born to diabetic mothers was only slightly higher with a rate of 10.4/1000, these findings were
significantly lower than the population in England. The authors were unsure about the reasons
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why these rates were so different from one country to another, and concluded by suggesting
further research.
GDM is not commonly associated with severe complications such as fetal death.
However, Uvena-Celebrezze and Catalano (2000) suggested even though perinatal mortality is
most often associated with pregnancies complicated by type 1 DM, it does occur in GDM
pregnancies as well. They reported that these deaths usually occurred before a diagnosis of
glucose intolerance or with very poor glycemic control during the pregnancy.
To summarize, having any type of diabetes during pregnancy carries a risk for
spontaneous abortion, stillbirth, and perinatal mortality. Those women who have pregestational
diabetes are at an even higher risk for fetal loss. Good glycemic control and prenatal care can
significantly lower these risks. (Brydon et al., 2000; Casson et al., 1997; Langer & Conway, 2000;
Lauenborg et al., 2003; Penny et al., 2003; Platt et al., 2002; Wylie et al. 2002).
Macrosomia and Large for Gestational Age
Reeder et al. (1997) define macrosomia as “excessive fetal growth” with a “birth weight in
excess of 4,000 to 4,500 grams.” These authors defined large for gestational age as “a neonate
weighing above the 90th percentile for the gestational age. Large for gestational age infants are
immature but overgrown and are typical of diabetic mothers.” Although these two terms are
defined differently, they are often categorized together when birth weight is discussed and are
often used interchangeably.
These conditions are related to several complications during labor of the infant.
According to Thoenen et al. (2001), excessive fetal growth can cause shoulder dystocia at birth
(complication in oversized infants whose large shoulders catch at the pelvic brim or outlet,
(Reeder et al., 1997), traumatic birth injury, and/or asphyxia. Current literature consistently
associates these conditions with pregnancies complicated by diabetes. Thoenen et al. (2001)
stated that from 1990-1999, West Virginia mothers with diabetes had a higher percentage
(17.2%) of babies weighing more than 4,000g than did West Virginia mothers without diabetes
(10.0%).
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Type 1 DM is associated with an increased risk of macrosomia. Casson et al. (1997)
found that macrosomia was more common among the “insulin dependent” diabetic mothers in
their study compared to the general population. They also stated that these findings coincided
with findings from their review of literature.
Penny et al. (2003) found similar results in their study of pregnancies complicated by type
1 DM. They found that 55% of their sample weighed above the 90th centile for babies in the
Aberdeen, Scotland population. Platt et al. (2002) also found an association between increased
fetal weight and type 1 DM. Their research results show that after being corrected for gestational
age, the birth weight of infants born to mothers with type 1 DM was greater than those infants
born to mothers without diabetes. Wylie et al. (2002) found a significantly higher rate of LGA,
shoulder dystocia, and birth injury in infants of type 1 mothers. Out of the infants they analyzed
over a 10-year period, 22. 5% (61 infants) weighed more than 4,000g and 4.1% (11 infants)
weighed more than 4,500g.
Much research has linked type 2 DM during pregnancy to increased fetal size. In fact, in
a comparison between outcomes of pregnancies complicated by type 2 DM with pregnancies
complicated by type 1 DM, Brydon et al. (2000) found that babies born to mothers with type 2 DM
were more likely to be born large for gestational age compared to babies born to mothers with
type 1 DM. They associated the greater fetal size with suboptimal glycemic control as well as
increased maternal weight in the type 2 group (mean BMI >31.)
Dunne et al. (2003) found that 28% of the infants in their analysis of pregnancy in women
with type 2 DM were large for gestational age. Nine infants (5.6%) weighed between 4 and 4.5
kg (8.8-9.2 lbs) and six (3.7%) weighed more than 4.5kg.
GDM is commonly associated with macrosomia and large for gestational age infants
(American Diabetes Association, 2003; Brown & Hare, 1995; Davey, 2003; Hsu-Hage & Yang,
1999; Jensen et al., 2000; Jovanovic, 2001; Lee-Parritz & Heffner, 1995; Svare et al., 2001;
Uvena-Celebrezze & Catalano, 2000). Brown and Hare (1995) as well as Jovanovic (2001)
stated that macrosomia is the most common neonatal outcome attributed to gestational diabetes.
In a review of literature on GDM, Uvena-Celebrezze and Catalano (2000) stated that macrosomia
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and large for gestational age complicate almost 50% of all pregnancies in women with GDM.
These authors found several possible explanations for excessive fetal growth in infants of women
with GDM, including maternal pregravid (pre-pregnancy) weight, maternal weight gain during
pregnancy, maternal glucose, amino acid, and lipid levels as well as an increase in infant insulin
production due to increased maternal glucose levels. Jensen et al. (2000) found that macrosomia
affected 14% of the infants born to mothers with GDM in their study, compared to only 6% of
infants in the control group. Svare et al. (2001) had similar findings with an increased frequency
of macrosomia in infants born to mothers with GDM compared to non-diabetic controls; the
increase was not statistically significant, however.
To summarize, diabetes during pregnancy, whether it is type 1, type 2 or GDM is
associated with an increased risk for excessive fetal growth (American Diabetes Association,
2003; Brown & Hare, 1995; Brydon et al., 2000; Casson et al., 1997; Davey, 2003; Dunne et al.,
2003; Hsu-Hage & Yang, 1999; Jensen et al., 2000; Jovanovic, 2001; Lee-Parritz & Heffner,
1995; Penny et al., 2003; Platt et al., 2002; Svare et al., 2001; Thoenen et al., 2001; Wylie et al.,
2002). Several complications of delivery such as shoulder dystocia, birth injury, and asphyxia are
common when an infant is larger than normal for gestational age (Thoenen et al., 2001; Wylie et
al., 2002). The causes for excessive fetal growth in diabetic pregnancies are still unknown, but
possible explanations include maternal weight and maternal glycemic control (Brydon et al., 2000;
Uvena-Celebrezze and Catalano, 2000).
Cesarean Section, Induction of Labor and Preterm Delivery
Cesarean delivery, as defined by Reeder et al. (1997), is “delivery of the fetus by an
incision through the abdominal and uterine walls”. These authors defined induction of labor as
“artificial initiation of labor after the fetus is viable”. They defined preterm delivery as a
spontaneous or therapeutic (early induction of labor by doctor) end of pregnancy after the age of
viability, but before the end of full term gestation, which is 37 weeks.
Thoenen et al. (2001) stated: “Women with diabetes are more likely to suffer one or more
complications of labor and/or delivery (such as cesarean section, preterm delivery or induction of
labor) than are women who do not have diabetes”. These researchers found that from 1990-
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1999, 43.3% of West Virginia women with diabetes had one or more complications of labor and/or
delivery compared to 33.0% of West Virginia women without diabetes having complications of
labor and/or delivery.
Wylie et al. (2002) found that the incidence of cesarean delivery was high among
mothers with type 1 DM. They found that 49% of the type 1 pregnancies in their study ended in
caesarian section, which is comparable to the 45-67% that was reported in their review of
literature. Labor was induced in 188 of the 300 consecutive pregnancies in this study for a variety
of reasons, including large for gestational age, macrosomia, hypertension and fetal distress.
Type 2 DM is also associated with higher numbers of complications of labor and delivery
as well. Dunne et al. (2003) found a slightly higher number (95, 53%) of emergency or elective
cesarean deliveries than of vaginal deliveries (87, 47%). Twenty-one of the 95 cesarean
deliveries were preceded by early induction of labor.
Cesarean deliveries and early induction of labor were found to be positively correlated
with gestational diabetes mellitus (GDM) in a comparison to non-diabetic controls according to
Jensen et al., 2000. Their results show that 33% of the GDM pregnancies were delivered through
cesarean section compared to 21% of non-diabetic pregnancies. They also state that 61% of the
GDM group resulted in an induction of labor compared to only 24% of the non-diabetic group.
Sendag et al. (2001) found similar results in their study of gestational diabetes and
perinatal outcomes. Their results showed that percentages of both cesarean sections and
preterm delivery occurred significantly more often in the group with GDM than in the non-diabetic
control group.
Svare et al. (2001) found slightly different results in their look at perinatal complications
and gestational diabetes mellitus. They found that the GDM group had a significantly higher
frequency of induced labor than the non-diabetic controls; however, there were no differences
between the amount of cesarean deliveries or pregnancy complications between the two groups.
Often, the increased risk for cesarean and/or preterm delivery is correlated with the
higher incidence of large for gestational age infants and macrosomia. As discussed earlier, these
complications are more common in the infants of mothers with diabetes. Blatman and Barss,
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1995, stated that maternal diabetes by itself is not a certain indication for cesarean section,
however, macrosomia and large for gestational infants along with the associated problem of
shoulder dystocia are indications for cesarean section.

Harvard (2002) reported that doctors will

often induce labor or cesarean section if the fetus seems to be too large for normal vaginal
delivery. The results of Brydon et al. (2000) differed from these statements, however. In their
comparison of pregnancies complicated by type 1 and type 2 DM, they found that even though
there was a higher incidence of babies that were large for gestational age in the type 2 group
than in the type 1 group, the type 2 group had more vaginal deliveries. However, they did find a
significantly higher number of preterm deliveries in the infants born to type 2 mothers than to type
1 mothers.
To review, complications of labor and delivery—namely cesarean section, induction of
labor and/or preterm delivery (either spontaneous or medically induced) have been found to be
more common in pregnancies complicated by type 1 DM, type 2 DM, or GDM (Blatman & Barss,
1995; Dunne et al., 2003; Harvard, 2002; Jensen et al., 2000; Svare et al., 2001; Thoenen et al.,
2001; Wylie et al., 2002). According to Blatman and Barss (1995) and Harvard (2002), the
increased percentage of delivery complications in diabetic pregnancies is linked to the higher
percentage of excessively large babies in diabetic pregnancies. There is some debate, however,
about this association (Brydon et al., 2000).
Pregnancy-Induced Hypertension
Pregnancy-induced hypertension, according to Reeder et al. (1995), is a syndrome in
pregnant women characterized by hypertension, edema, and proteinuria (high levels of protein in
the urine.) Eclampsia and preeclampsia are categories of pregnancy-induced hypertension.
Pregnancy-induced hypertension has been found to affect women with type 1 DM, type 2 DM and
GDM more often than non-diabetic women.

Wylie et al. (2002) found that within their sample,

22.0% of women with type 1 diabetes had pregnancy-induced hypertension, while only 6.3% of
the non-diabetic controls were affected.
In an analysis of pregnancies complicated by type 2 DM, Dunne et al. (2003) found that
19.7% of women with type 2 DM had pregnancy-induced hypertension and/or preeclampsia
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compared to 10% of women who were not diabetic. They also found that fetal loss was more
common when the mother had pregnancy-induced hypertension/preeclampsia (8.7%) compared
to infants of women who did not have pregnancy-induced hypertension/preeclampsia (2.7%).
In a comparison between hypertensive disorders of pregnancy between women with type
1 and type 2 DM, Cundy et al. (2002) found that the incidence of hypertension during pregnancy
was similar between the two groups of women. They did find, however, that certain aspects of
the hypertension differed between type 1 and type 2 women. For instance, women with type 2
DM had more chronic hypertension (diagnosed at < 20 weeks gestation) than did women with
type 1 DM. The impact of hypertension of adverse outcomes of pregnancy was significantly more
severe for women with type 1 DM compared to women with type 2 DM, though.
Sibai et al. (2000) did not specify between types of diabetes, but found that the frequency
of preeclampsia rose with increasing severity of diabetes in women with pregestational diabetes.
In this study of 462 women with pregestational diabetes, they also found that the women with
preeclampsia in their study had a significantly higher rate of preterm delivery (56.5%) compared
to those without preeclampsia (33.3%).
GDM is associated with an increased risk for maternal hypertensive disorders (American
Diabetes Association, 2003; Hsu-Hage & Yang, 1999; Jensen et al., 2000; Sendag et al., 2001).
Sendag et al. (2001) found that there was double the amount of women in the GDM group with
hypertensive disorders (9.4%) compared to the non-diabetic controls (4.3%). Jensen et al. (2000)
illustrated similar results of their comparison of pregnancies complicated by GDM compared with
non-diabetic controls. GDM patients were treated with diet, tolbutamide, and insulin. Even with
treatment there were 19.6% of women with hypertensive disorders in the GDM group while there
were 10.5% of women with hypertensive disorders in the non-diabetic group.
To summarize, pregnancy-induced hypertension is more common in women with type 1
DM, type 2 DM, or GDM compared to women without diabetes. The timing of onset and the
impact on adverse outcomes of pregnancy may differ between women with different types of
diabetes (Cundy et al., 2002.)
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Preexisting Diabetes-Related Complications
As previously stated, Type 1 and Type 2 DM are linked to several co-morbidities such as
cardiovascular disease, neuropathy, nephropathy, and retinopathy. Pregnancy can lead to
further complication of these disorders, especially eye and kidney disease (Harvard, 2002;
Thoenen et al., 2001). Brown and Hare (1995) stated that these conditions increase the risk for
poor gestational outcomes for both mother and baby. Several researchers have suggested that
in order to prevent or lessen the effects of these conditions the first important step is early
diagnosis, preferably before pregnancy, and the second important step is optimal glycemic
control (American Diabetes Association, 2002; Rosenn & Miodovnik, 2000.)
Conclusion
Diabetes is a serious problem in West Virginia. In turn, many pregnancies in the state
are complicated by the disease (Thoenen et al., 2001). Both pregestational DM and GDM are
linked to adverse perinatal outcomes. Type 1 and Type 2 DM have been linked to complications
of pregnancy such as congenital anomalies, fetal loss, excessive fetal growth, problems of labor
and delivery and maternal hypertension (American Diabetes Association, 2002; Blatman & Barss,
1995; Brydon et al., 2000; Casson et al., 1997; Cundy et al., 2002; Dunne et al., 2003; Farrell et
al., 2002; Harvard, 2002; Hawthorne et al., 2000; Langer & Conway, 2000; Lauenborg et al.,
2003; Loffredo et al., 2001; Moore et al., 2000; Penny et al., 2003; Platt et al., 2002; Sibai et al.,
2000; Thoenen et al., 2001; Väärasmäki et al., 2002; Wylie et al., 2002). Pregnancy can also
cause pre-existing diabetes related health disorders such as neuropathy, nephropathy,
retinopathy, and cardiovascular disorders to be further aggravated (Brown & Hare, 1995; Rosen
and Miodovnik, 2000; Thoenen et al., 2001). GDM is also linked to adverse perinatal outcomes,
namely excessive fetal growth, problems of labor and delivery (commonly because of large fetal
size) and maternal hypertension (American Diabetes Association, 2003; Brown & Hare, 1995;
Davey, 2003; Hsu-Hang & Yang, 1999; Jensen et al., 2000; Jovanovic, 2001; Lee-Parritz &
Heffner, 1995; Sendag et al., 2001; Svare et al, 2001; Uvena-Celebrezze & Catalano, 2000).
The research analyzed in this review lead to the hypothesis that pregnancies
complicated by maternal diabetes are linked to more negative perinatal outcomes than are
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pregnancies to mothers without diabetes. A secondary hypothesis tested was that Type 1 and
Type 2 diabetes are associated with more severe negative perinatal outcomes than is gestational
diabetes.
There is a lack of research for the state of West Virginia that gives an in depth analysis of
the association between diabetes and specific types of negative perinatal outcomes. There is
also no research for the state of West Virginia and a lack of national data that analyzes the
association between specific types of maternal diabetes and perinatal outcomes. A populationbased analysis and comparison of pregnancies of West Virginia women with pregestational and
gestational diabetes as well as non-diabetic WV women was done to research these hypotheses.
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METHODOLOGY

Research Design
This study was a causal-comparative (ex post facto) research design with secondary data
analysis. The independent variable was the presence or absence of diabetes in the mothers.
The dependent variable was perinatal outcomes. There was also further analysis on the
differences between perinatal outcomes (secondary dependent variable) of women with
pregestational diabetes and gestational diabetes (secondary independent variable). There was a
primary division of the population into two groups of women. The first group consisted of women
with type 1, type 2 or gestational diabetes. The second group consisted of non-diabetic women.
The diabetic group was then subdivided into two groups consisting of women with gestational
diabetes and women with pregestational diabetes.
Non-modifiable variables controlled for in both groups were: number delivered at birth
(only singular births were used) and Medicaid funding (all women in the study were enrolled in
Medicaid at the time of their pregnancy). Confounding variables for both groups were maternal
glycemic control and maternal weight. Moderating variables analyzed included: sex of the child,
age of mother, race of mother, education level of mother, pregnancy history (including number of
live births now living and number of live births now dead), month prenatal care began, number of
prenatal visits, infant birth weight, clinical estimate of gestational age, one minute and five minute
APGAR scores, medical risk factors of the mother (cardiac disease, diabetes, chronic
hypertension, pregnancy-induced hypertension, previous infant >4000g, previous pre-term or
small for gestational age infant, renal disease, tobacco use, and alcohol use), complications of
labor and/or delivery, method of delivery, abnormal conditions of the newborn, congenital
anomalies, and fetal loss.
Population
This was a population-based study consisting of all singular births to West Virginia
mothers enrolled in Medicaid during the years 2001 and 2002. These births were identified by
state-certified birth certificate data from West Virginia Vital Registration Office in the Bureau for
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Public Health. Births were also identified through the West Virginia Birth Score Project, which
has collected data from all births in West Virginia hospitals for the two years.
The total number of births in West Virginia for the years 2001 and 2002 was 40,708. The
total number of births for the West Virginia Medicaid population for those two years was 22,257.
After controlling for singular births and after matching up I.D. numbers from the Vital Statistics
data to the Medicaid data, the total study population consisted of 14,583 women. The nondiabetic group consisted of 13,730 women while the diabetic group consisted of 853 women. The
pregestational group consisted of 396 women while the gestational group consisted of 457
women. All demographic information was self-reported by the mothers and included age, race
and education level.
Procedures
Data on 2001 and 2002 West Virginia birth outcomes were from three separate data
collections and were obtained through two different sources. One data source was the West
Virginia Birth Score Project. This is a project through West Virginia University that collects data
on all West Virginia births. These data are collected from all hospitals in the state where births
take place. This data set also included West Virginia Vital Statistics, which are data that is
collected by the West Virginia Bureau for Public Health on all West Virginia births that have been
identified with a state-certified birth certificate. The data from the West Virginia Birth Score
Project included all variables listed in the above “research design” section.
The second source of data was West Virginia Medicaid claims data. ID numbers for
women enrolled in Medicaid were matched using ID numbers from the West Virginia Birth Score
Project. This was done to better identify those women with diabetes and to categorize the women
with diabetes as pregestational or gestational.
Diabetes and type of diabetes were identified using the Medicaid claims data and ICD-9
coding. ICD-9 is the International Classification of Diseases, 9th revision (U.S. Department of
Health and Human Services, 1991). Medicaid uses these codes to classify its patients’ claims.
Any women from our population with a Medicaid claim including an ICD-9 code indicating
diabetes was included in the diabetes group. The diabetes group was then divided into

21
pregestational and gestational by identifying those women whose Medicaid claims included codes
for Type 1, Type 2 or Gestational diabetes. Only women with one code for type of diabetes were
used. In other words, no women who had claims that overlapped into more than one type of
diabetes were used.
Data were analyzed for 28 total variables. The presence of diabetes and type of diabetes
were the two variables used to create the groups to be analyzed. Frequencies were run on eight
demographic variables (listed above in “population” section) and nine self-reported medical risk
factors. The other nine variables analyzed were perinatal outcomes.
The variable “Medical Risk Factors”, which was in the WV Vital Statistics data set,
included 17 different sub-fields which each represented a different type of medical risk factor selfreported by the mothers. Nine of those fields were analyzed including cardiac disease, diabetes,
chronic hypertension, pregnancy induced hypertension, previous infant >4,000g, previous preterm or small infant, renal disease, tobacco use and alcohol use.
The perinatal outcomes were analyzed according to the way data were collected for the
WV Vital Statistics. The variables were sometimes subdivided into groups that differed from the
original data set because different groupings of the variable meant different health outcomes.
For example, infant birth weight was divided into three categories according to what Reeder et al.
(1997) defined as low-birth weigh infants, <2,500g/5.5lbs and infants with macrosomia,
>4,000g/8.2lbs. The third category was those infants that fell in between these two groups, 2,
540g/5.6lbs. Birth weights for this study were divided into the three categories of <5lbs, 5-8lbs
and >8lbs.
Clinical estimate of gestational age was broken into the two categories, ≥37 weeks and
<37 weeks. These groupings were created according to what Reeder et al. (1997) called full
term, which is 37 weeks.
Apgar scores, which are defined by Reeder et al. (1997) as a scoring system with a
maximum score of 10 that rates the condition of a newborn according to heart rate, respiratory
effort, muscle tone, reflex irritability, and color. The variable was split into three categories that
Reeder et al. (1997) illustrate. A score of 0-3 indicates that the infant is in very poor condition
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and that resuscitation is needed immediately. A score of 4-6 indicates that the infant is in fair
condition and needs to be closely monitored. Finally, a score of 7-10 indicates that the infant is in
good condition.
The perinatal outcomes of “complications of labor and/or delivery,” “congenital
anomalies” and “abnormal conditions of the newborn” also contained different sub-fields which
each represented a different condition. For these variables a Yes/No frequency was run to
compare the number of times women from each of the groups experienced these outcomes.
Frequency distributions for each subfield were run in order to find which sub-fields occurred most
often in the population. Appendix B shows which complications of labor and/or delivery and
which complications of labor and/or delivery and which congenital anomalies were considered
during data collection of the WV Vital Statistics.
For “method of delivery” women were placed in either the vaginal delivery category or the
cesarean section delivery. This decision was based on the findings from the literature review
which state that women with diabetes may be more likely to have cesarean sections than women
without diabetes (Blatman & Barss, 1995; Dunne et al., 2003; Harvard, 2002; Jensen et al., 2000;
Svare et al., 2001; Thoenen et al., 2001; Wylie et al., 2002).
Fetal loss was determined by running a frequency on the presence of date of death.
There was not a time frame between birth and date of death used. Those infants that had a date
of death were categorized as a fetal loss.
All data were analyzed using the Statistical Analysis System (SAS). Frequencies were
run on all variables. Chi Squares or Fisher’s Exact Tests (when any expected cell size was <5)
were used to compare the diabetic to the non-diabetic group in respect to perinatal outcomes and
to compare the pregestational group to the gestational group in respect to perinatal outcomes.
Instrumentation
Data were used from preexisting databases from the West Virginia Vital Registration,
which is recorded from birth certificates, from the West Virginia Birth Score Project, which is
compiled from hospital records which are completed at the time of birth, and from West Virginia
Medicaid claims data.
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Table 1: Perinatal Outcomes-Diabetics compared to Non-diabetics

Perinatal Outcomes
(N=14,583)
Birth Weight
<5lbs (N=1251)
5-8 lbs (N=9564)
>8lbs (N=2912)
Clinical Estimate of Gestational
Age
<37 weeks (N=1634)
1 Min. Apgar
0-3 (N=295)
4-6 (N=848)
7-10 (N=13403)
5 Min. Apgar
0-3 (N=35)
4-6 (N=164)
7-10 (N=14346)
Complications of Labor and/or
Delivery
Yes (N=664)
Congenital Anomalies
Yes (N=45)
Abnormal Conditions of the
Newborn
Yes (N=139)
Method of Delivery
Cesarean Section N=(922)
Fetal Loss
Yes (N=102)

Diabetic
(N=853)

Non-Diabetic
(N=13,730)

Chi Square p value/Fisher’s
Exact Test (FE) Pr<= P

No.

Row Pct.

No.

Row Pct.

58
506
229

6.80
59.32
26.85

1193
9058
2683

8.69
65.97
19.54

.0559
<.0001
<.0001

159

18.77

1475

10.80

<.0001

21
75
756

2.46
8.79
88.63

274
773
12647

2.00
5.63
92.11

.3479
.0001
.0003

2
11
839

.23
1.29
98.36

33
153
13507

.24
1.11
98.38

1.000 FE
.6377
.9695

48

5.63

616

4.49

.1210

4

.47

41

.30

.3344 FE

8

.94

131

.95

.9622

46

5.39

876

6.38

.2502

9

1.06

93

.68

.1990
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Table 2: Medical Risk Factors-Diabetics compared to Non-Diabetics

Cardiac Disease
Yes (N=24)
Diabetes
Yes (N=70)
Chronic Hypertension
Yes (N=155)
Preg. Induced Hypertension
Yes (N=41)
Previous Infant >4000g
Yes (N=163)
Previous pre-term or small infant
Yes (N=163)
Renal Disease
Yes (N=36)
Tobacco Use
Yes (N=6036)
Alcohol Use
Yes (N=80)

Non-Diabetic
(N=13,730)

Diabetic
(N=853)

Medical Risk Factors
(N=14,583)
No.

Row Pct.

No.

10

1.17

14

.10

<.0000 FE

20

2.34

50

.36

<.0000 FE

19

2.23

136

.99

.0006

6

.70

35

.25

.0307 FE

3

.35

19

.14

.1347 FE

10.43

74

.54

<.0001

.12

35

.25

.7220 FE

5745

42.15

<.0001

89
1
291
8

34.32
.95

72

Row Pct.

Chi-Square p value/Fisher’s
Exact Test (FE)
Two Sided Pr <= P

.53

.1434 FE
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Table 3: Perinatal Outcomes-Pre-Gestational compared to Gestational Diabetes

Perinatal Outcomes
(N=853)
Birth Weight
<5lbs (N=58)
5-8 lbs (N=506)
>8lbs (N=229)
Clinical Estimate of Gestational
Age
<37 weeks (N=159)
1 Min. Apgar
0-3 (N=21)
4-6 (N=75)
7-10 (N=756)
5 Min. Apgar
0-3 (N=2)
4-6 (N=11)
7-10 (N=839)
Complications of Labor and/or
Delivery
Yes (N=48)
Congenital Anomalies
Yes (N=4)
Abnormal Conditions of the
Newborn
Yes (N=8)
Method of Delivery
Cesarean Section N=(46)
Fetal Loss
Yes (N=9)

Pre-Gestational
(N=396)
No.

Row Pct.

Gestational
(N=457)
No.

Row Pct.

Chi Square P value/Fisher’s
Exact Test(FE)
Two-Sided Pr <=P

33
207
124

8.33
52.27
31.31

25
299
105

5.47
65.43
22.98

.0976
<.0001
<.0061

96

24.49

63

13.85

<.0001

16
39
341

4.04
9.85
86.11

5
36
415

1.09
7.88
90.81

.0056
.3107
.0311

1
8
387

.25
2.02
97.73

1
3
452

.22
.66
98.91

1.000 FE
.0783
.1766

30

7.58

18

3.94

.0215

4

1.01

0

0.00

.0461 FE

4

1.01

4

.88

1.000 FE

17

4.29

29

6.35

.1856

7

1.77

2

.44

.0898 FE
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Table 4: Medical Risk Factors-Pre-Gestational compared to Gestational Diabetes

No.
Cardiac Disease
Yes (N=10)
Diabetes
Yes (N=20)
Chronic Hypertension
Yes (N=19)
Preg. Induced Hypertension
Yes (N=6)
Previous Infant >4000g
Yes (N=3)
Previous pre-term or small infant
Yes (N=89)
Renal Disease
Yes (N=1)
Tobacco Use
Yes (N=291)
Alcohol Use
Yes (N=8)

Gestational
(N=457)

Pre-Gestational
(N=396)

Medical Risk Factors
(N=853)

Row Pct.

No.

7

1.77

3

.66

.2015 FE

14

3.54

6

1.31

.0324

8

2.02

11

2.41

.7026

5

1.26

1

.22

.1019 FE

1

.25

2

.44

1.000 FE

65
1
131
1

16.41
.25
33.33
.26

Row Pct.

Chi-Square p value/Fisher’s
Exact Test (FE)
Two Sided Pr <= P

24

5.25

<.0001

0

0.00

.2824 FE

35.16

.5754

1.54

.0753 FE

160
7
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RESULTS
Demographic Information
Of the total population, 48.57% of the infants born were female while 51.43% were male.
The non-diabetic group consisted of 48.70% female infants and 51.30% male infants while the
diabetic group consisted of 46.58% female infants and 53.42% male infants.
The range of ages for the total population of women was 14-57 with the mean age being
23.50. The non-diabetic group had an age range of 16-44 with a mean age of 26.06 while the
diabetic group had a larger age range of 14-57 with a mean age of 23.33. The majority of the
mothers in the study were white making up 94.94% of the total population. Black mothers made
up 3.55% of the population while “other” races made up .51% of the population. The variable
“highest level of education completed” was broken up into 6 categories. Of the total population of
women 3.72% had no high school education, 27.34% had some high school education (1-3yrs),
48.80% graduated from high school, 18.56% had 1-4 years of college and .99% had 5+ years of
college.
The mothers also reported on pregnancy history and prenatal care. A total of 7,645
(52%) of all women in the population had a previous birth of a child who is now living. Two
hundred and nineteen women (.015%) of women in the population had a previous birth of a child
who is now dead. The month prenatal care began was reported using numbers from 0-9 with
each number representing that month of pregnancy. The mean for the month that prenatal care
began was 2.68 for the total population. The mean number of total prenatal visits was 11.56 for
the entire population, 11.47 for the non-diabetic population and 13 for the diabetic population.
Diabetic and Non-Diabetic Comparisons
The perinatal outcomes of the diabetic group and the non-diabetic group are summarized
in Table 1. The table displays total numbers for each perinatal outcome as well as row
percentage according to chi-squares run on each one. The row percentage is the percentage of
women in that category with that perinatal outcome. The table also displays p values for
comparisons between row percentages in the diabetic group and row percentages in the nondiabetic group.
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Looking at Birth Weight we see that the non-diabetic group had a significantly higher
percentage of women who had infants falling in the 5-8lb category than did the diabetic group
(p = <.0001). Also shown is that the women in the diabetic group had a significantly higher
percentage of babies weighting >8lbs.
The diabetic group had a significantly higher percentage of infants born before full
gestation (37wks) (p = <.0001). It is shown that 18.77% of the diabetic group delivered before 37
weeks while 10.80% of the non-diabetic group delivered before full term.
There were several significant differences between the two groups in the one-minute
Apgar scores but no significant associations were shown between presence of diabetes and fiveminute Apgar scores. The diabetic group had a significantly higher percentage of women who
delivered infants with one-minute Apgar scores in the 4-6 range (p = .0001) while the non-diabetic
group had a significantly higher percentage of women whose infant’s one-minute score was in the
7-10 range (p = .0003).
When looking at associations between presence of diabetes and complications of labor
and/or delivery, congenital anomalies, abnormal conditions of the newborn, method of delivery
and fetal loss, there were no significant differences between the diabetic and non-diabetic groups.
Frequency distributions were run to find which complications of labor and/or delivery and
which congenital anomalies occurred most often in the entire population. The most frequently
occurring complications of labor and/or delivery were use of anesthetic, abruptio placenta, and
fever. The most frequently occurring congenital anomalies were cleft lip/palate, “other”
circulatory/respiratory problems and anencephalus. There is further explanation of these in the
Discussion section.
Table 2 summarizes the self-reported medical risk factors of the diabetic and non-diabetic
groups. A significantly higher percentage of the diabetic group reported having cardiac disease
(p = <.0000), chronic hypertension (p = .0006), pregnancy-induced hypertension (p = .0307) and
previous pre-term or small for gestational infants (p = <.0001) than did the non-diabetic group.
The non-diabetic group, however, did report a significantly higher percentage of tobacco use than
did the diabetic group (p = <.0001). The non-diabetic group also had a significantly higher
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percentage of women self-reporting that they had diabetes than did the women who were in the
diabetes group (p = <.0000).
Pre-gestational and Gestational Comparisons
As shown in table 3 the gestational group had a significantly higher percentage of women
who had babies in the 5-8lb weight range than did the pre-gestational group (p = <.0001). The
pre-gestational group had a significantly higher percentage of women who delivered infants who
weighed more than 8lbs than did the women in the gestational group (p = <.0061). The pregestational group also had a significantly higher percentage of women who delivered before full
term of 37 weeks (<.0001).
Looking at one-minute Apgar scores we see that the pre-gestational group had a
significantly higher percentage of women whose infants were in the 0-3 range (p = .0056), which
according to Reeder, Martin and Koniak-Griffen (1997) means a need for resuscitation of the
infant. The Gestational group, however, had a significantly higher percentage of women whose
infants fell into the 7-10 range (p = .0311).
The pre-gestational group had a significantly higher percentage of women who had some
type of complication of labor and/or delivery (p = .0215) as well as a significantly higher
percentage of women whose infant had a congenital anomaly (p = .0461) than did the gestational
group. There were no significant associations shown between type of diabetes and five-minute
Apgar scores, abnormal conditions of the newborn, method of delivery or fetal loss.
Table 4 displays the analysis of the self-reported medical risk factors for the pregestational group and the gestational group. The pre-gestational group reported significantly
higher percentages of diabetes (p = .0324) and previous pre-term or small infants (p = <.0001)
than did the gestational group.
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DISCUSSION
Interpretation
Birth weight
Having any type of diabetes during pregnancy is associated with an increased risk for
macrosomia (American Diabetes Association, 2003; Brown & Hare, 1995; Brydon et al., 2000;
Casson et al., 1997; Davey, 2003; Dunne et al., 2003; Hsu-Hage & Yang, 1999; Jensen et al.,
2000; Jovanovic, 2001; Lee-Parritz & Heffner, 1995; Penny et al., 2003; Platt et al., 2002; Svare
et al., 2001; Thoenen et al., 2001; Wylie et al., 2002). This was supported in this research study.
Looking at table 1 we see a significant association was shown between maternal diabetes and
infants with macrosomia. In turn there was a significant association between not having diabetes
and delivering a baby that weighed 5-8lbs (normal newborn weight range according to Reeder et
al., 1997). This weight range is what these authors suggested is the healthiest range for a
newborn to be in.
Table 3 shows that when comparing pre-gestational diabetes and gestational diabetes in
relation to birth weight we see macrosomia occurred in both groups of women but occurred
significantly more often in the pre-gestational group.
Clinical Estimate of Gestational Age
Pre-term delivery-as well as other complications of labor and delivery- has been more
commonly reported in pregnancies complicated by diabetes than in those that are not (Blatman &
Barss, 1995; Dunne et al., 2003; Harvard, 2002; Jensen et al., 2000; Svare et al., 2001; Thoenen
et al., 2001; Wylie et al., 2002). Blatman and Barss (1995) and Harvard (2002) attribute this
higher incidence of pre-term delivery to a higher percentage of macrosomia in babies of diabetic
women. Table 1 shows that in this study both preterm delivery (delivery before 37 weeks
gestation) and macrosomia (discussed above) occurred significantly more often in the diabetic
group than in the non-diabetic group.
Again, table 3 shows that even though both diabetes groups had occurrences of pre-term
delivery, the pre-gestational diabetes group had a significantly higher percentage of babies
delivered before 37 weeks than did the gestational group.
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Apgar Scores
Apgar scores were analyzed because they give a rating of health at birth that includes
several factors including heart rate, respiratory effort, muscle tone, reflex irritability, and color
(Reeder et al., 1997). In table 1 we see that the diabetic group had a significantly higher
percentage of newborns falling within the 4-6 score range while the non-diabetic group had a
significantly higher percentage falling within the 7-10 range. According to Reeder et al. (1997) in
their explanation of Apgar scores, this would mean that significantly more women in the diabetic
group had had infants whose score indicated only fair health status and a need for close
monitoring. In turn, the women’s infants in the non-diabetic group were more likely to be in
optimal health score range.
When comparing the Apgar scores of the infants born to the pre-gestational group and
the gestational group (table 3), the gestational group had a significantly higher percentage of
newborns falling in the 7-10 score range, which again is the most desired outcome when
observing Apgar scores. The pre-gestational group did also have a higher percentage of
newborns that had scores in the 0-3 range, which indicates a need for resuscitation (Reeder et
al., 1997), but it was not a significant difference.
Complications of Labor and/or Delivery
There was no previous research found that supported an association between the
complications of labor and delivery accounted for in the WV Vital Statistics database used for this
study (see Appendix B) and presence of diabetes in mothers. Thoenen et al. (2001) and Reeder
et al. (1997), however, both stated that certain problems of labor and delivery such as shoulder
dystocia, traumatic birth injury, and/or asphyxia can occur in mothers whose infant has
macrosomia, which a significant percentage of this population did. These complications were not
accounted for in the Vital Statistics data.
Out of the total population of 14,583 pregnancies only 664 (4.55%) had some
complication of labor and/or delivery. There was no significant difference between the diabetic
group and the non-diabetic group in relation to this variable. There were three complications of
labor and/or delivery that occurred most often within the population. Use of anesthetic occurred
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in a total of 100 women (.69%) Abruptio Placenta, which is a premature separation of the
implanted placenta and is considered a medical emergency (Reeder et al., 1997) occurred in 85
women (.58%). Fever was the third most frequently occurring complication and it occurred in 79
women (.54%).
A significantly higher percentage of women in the pregestational group experienced
some type of complication of labor and/or delivery compared to the gestational group. The three
most frequently occurring complications of labor and/or delivery were the same in the diabetic
group as in the total population.
Congenital Anomalies
Research has shown that an association exists between having pregestational diabetes
and delivering an infant with a congenital anomaly (American Diabetes Association, 2002; Brydon
et al., 2000; Casson et al., 1997; Dunne et al., 2003; Harvard, 2002; Langer & Conway, 2000;
Loffredo et al., 2001; Moore et al., 2000; Penny et al., 2003; Platt et al., 2002; Thoenen et al.,
2001; Väärasmäki et al., 2002). In this study, however, this association was only partially
supported. Table 1 shows that there was no significant difference in the percentage of women
whose infant had a congenital anomaly when comparing the diabetic population and the nondiabetic population. This could be due to the fact that only 45 (.31%) of the entire population’s
infants were diagnosed with a congenital anomaly.
There were three congenital anomalies that occurred most often in the entire population
including cleft lip/palate, “other” circulatory/respiratory problems and anencephalus. Cleft lip
indicates an incomplete closure of the infants lip (Reeder et al., 1997). Other
circulatory/respiratory problems would be those problems not specified in the Vital Statistics
codes (Appendix B). Anencephalus is defined as a complete or partial absence of the infant brain
and skull (Reeder et al., 1997).
There were a significantly higher percentage of women with pre-gestational diabetes
(1.01%) who had an infant with a congenital anomaly compared to the percentage of women with
gestational diabetes who had an infant with a congenital anomaly (0.00%). This is supported in
research done by Uvena-Celebrezze and Catalano (2000). These authors reported that within
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current literature on the topic, infants of women with GDM carry the same risk for congenital
anomalies as the non-diabetic population.
Method of Delivery
A positive association between a need for cesarean section as method of delivery and
maternal diabetes has been strongly supported in current literature (Blatman & Barss, 1995;
Dunne et al., 2003; Harvard, 2002; Jensen et al., 2000; Svare et al., 2001; Thoenen et al., 2001;
Wylie et al., 2002). However, in this study, this association was not supported. As displayed in
table 1, there was no significant difference between the percentages of cesarean section
deliveries in the diabetic group compared to the non-diabetic group.
Fetal Loss
Fetal loss through spontaneous abortion, stillbirth, and perinatal mortality has been
positively associated with maternal diabetes (Brydon et al., 2000; Casson et al., 1997; Dunne et
al., 2003; Hawthorne et al., 2000; Langer and Conway, 2000; Lauenborg et al., 2003; Penny et
al., 2003). This association was not supported by this research. Table 1 shows that there was no
significant difference between the diabetic group and the non-diabetic group in respect to
percentages of fetal loss.
Table 3 displays that there was no difference in percentages of fetal loss between
gestational diabetics and pre-gestational diabetics. There was no previous literature found to
support this.
Medical Risk Factors
It is known that diabetes is associated with several chronic conditions such as renal
disease, retinopathy, cardiovascular disease, and neuropathy. It is also known that tobacco use
and hypertension can increase the risk of these conditions (Franz, 2001). Pregnancy itself can
lead to further complication of retinopathy and renal disease (Harvard, 2002; Thoenen et al.,
2001). These conditions have also been found to increase the risk for poor gestational outcomes
for both mother and baby (Brown and Hare, 1995).
The above information is why the seven self-reported medical risk factors were analyzed
in this study. Another reason for analysis was to show what percentages of women were
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experiencing these risk factors and how many women were actually reporting them for state data
collection. Significantly more women with diabetes reported cardiac disease, diabetes, chronic
hypertension, pregnancy induced hypertension and/or previous pre-term or small infants than did
those women without diabetes. There was also a significantly higher percentage of non-diabetic
women who used tobacco during their pregnancy compared to those women who were diabetic.
A surprisingly high percentage (41.69%) of women in the total population reported using tobacco
during their pregnancy.
Conclusions
It was hypothesized that in West Virginia women, pregnancies complicated by maternal
diabetes are linked to more negative perinatal outcomes than are pregnancies not complicated by
diabetes. This hypothesis was partially supported in this research. Although there were not
necessarily “more” negative perinatal outcomes in the diabetic group, there were several perinatal
outcomes that were significantly more associated with the diabetes group than with the nondiabetic group. These perinatal outcomes included macrosomia, pre-term delivery, and infants
with 4-6 range Apgar scores.
A secondary hypothesis analyzed was that Type 1 and Type 2 diabetes (pregestational)
are associated with more severe negative perinatal outcomes than is gestational diabetes (GDM).
This hypothesis was supported in that macrosomia, per-term delivery, lower Apgar scores,
complications of labor and/or delivery, and congenital anomalies all occurred significantly more
often in the pre-gestational group than in the gestational group.
Limitations of the Study
There were several limitations of this study. The medical risk factors used were selfreported by the mothers. The category “diabetes” shows that discrepancies did exist between
facts and the data collected from the birth certificates. WV Medicaid claims data showed that of
the 14,583 women in our study, 853 of them were diabetic. Only 20 of the women in the diabetic
group (according to the Medicaid data) reported that they had diabetes on their child’s birth
certificate. Of the non-diabetic group, 50 women reported that they had diabetes on their child’s
birth certificate.
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Another limitation of the study was that the data collected by WV Vital Statistics did not
include all information that I wished to include in my study. For example, several complications
of labor and/or delivery were found to be positively associated with diabetes in the review of
literature, but they were not included within Vital Statistics data collection (discussed in
Discussion section).
One final limitation of this study is that because the women in this study were all enrolled
in Medicaid, the results cannot be generalized to the entire West Virginia population or to the
entire diabetes population. Research has shown that socioeconomic status is positively
associated with health status (Adler and Ostrove, 1999; “Socioeconomic Condition”, 1999). This
means that due to the lower socioeconomic status of the population in this study (Medicaid
patients) their health status may be poorer than that of that general population.
Application of the Findings
The goals of this research were to determine the existence of negative birth outcomes
associated with diabetes and to begin to measure the extent of those negative outcomes. This
goal was achieved. This research can be used to implement future projects to help West Virginia
women with diabetes to have healthier pregnancies.
Additional Research Suggested
This research has supported the hypothesis that several perinatal outcomes including
birth weight, pre-term delivery, Apgar scores, complications of labor and delivery, as well as
congenital anomalies are significantly more common in women with pre-gestational diabetes than
in those with gestational diabetes. However, there is a lack of research available that compares
associations between perinatal outcomes and type of diabetes. In order to further support this
hypothesis, more research (such as prospective-longitudinal studies) is needed on the topic.
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